Feature

The push is on to recognize endometriosis in adolescents


 

Treatment dilemmas

The first-line treatment for dysmenorrhea and for suspected endometriosis in adolescents has long been empiric treatment with NSAIDs and oral contraceptive pills. Experts commonly recommend today that combined oral contraceptive pills (COCPs) be started cyclically and then changed to continuous dosing if necessary with the goal of inducing amenorrhea.

If symptoms are not well controlled within 3-6 months of compliant medication management with COCPs and NSAIDs and endometriosis is suspected, then laparoscopy by a physician who is familiar with adolescent endometriosis and can simultaneously diagnose and treat the disease should be considered, according to Dr. Laufer and several other experts in pediatric and adolescent gynecology who spoke with Ob.Gyn. News.

“If someone still has pain on one COCP, then switching to another COCP is not going to solve the problem – there is no study that shows that one pill is better than another,” Dr. Laufer said.

Yet extra months and sometimes years of pill-switching and empiric therapy with other medications – rather than surgical evaluation, diagnosis, and treatment – is not uncommon. “Usually, by the time a patient comes to me, they’ve already been on multiple birth control pills, they’ve failed NSAIDs, and they’ve often tried other medications as well,” such as progestins and gonadotropin-releasing hormone agonists, said Iris Kerin Orbuch, MD, director of the Advanced Gynecologic Laparoscopy Centers in New York and Los Angeles.

Pages

Recommended Reading

Should breast cancer screening guidelines be tailored to a patient’s race and ethnicity?
MDedge ObGyn
Ovarian masses: Surgery or surveillance?
MDedge ObGyn
Who needs breast cancer genetics testing?
MDedge ObGyn
Incision site for cesarean delivery is important in infection prevention
MDedge ObGyn
Treatment includes surgery
MDedge ObGyn
Rash goes undetected
MDedge ObGyn
Tip for when using phenazophyridine
MDedge ObGyn
FP can perform the circumcision
MDedge ObGyn
Uterine fibroids registry looks to provide comparative treatment data
MDedge ObGyn
FDA approves estradiol vaginal inserts for dyspareunia*
MDedge ObGyn

Related Articles